Similar articles

• Streptozotocin-induced hyperglycemia in rats: analysis of complement activity after streptozotocin administration.

  Perloff JR, Levy MM, Ketchum RJ, Read AD, White D, Brayman KL. Perloff JR, et al. Transplant Proc. 1995 Dec;27(6):3399. Transplant Proc. 1995. PMID: 8540017 No abstract available.
• Liver cysts in streptozotocin-treated rats.

  Sutherland DE, Matas AJ, Steffes MW, Najarian JS. Sutherland DE, et al. Transplantation. 1977 Aug;24(2):162-3. doi: 10.1097/00007890-197708000-00014. Transplantation. 1977. PMID: 143092 No abstract available.
• Neoplastic lesions in streptozotocin-treated rats.

  Okawa H, Doi K. Okawa H, et al. Jikken Dobutsu. 1983 Apr;32(2):77-84. doi: 10.1538/expanim1978.32.2_77. Jikken Dobutsu. 1983. PMID: 6225653
• Genetic control of diabetes induction by complete Freund's adjuvant combined with subdiabetogenic doses of streptozotocin in Lewis rats--evidence for transient cytotoxicity against beta cells.

  Ziegler B, Tietz S, Kohnert KD, Köhler E, Knospe S, Klöting I, Ziegler M. Ziegler B, et al. Exp Clin Endocrinol. 1987 Aug;89(3):269-75. doi: 10.1055/s-0029-1210649. Exp Clin Endocrinol. 1987. PMID: 2959492
• Diabetes mellitus-induced alterations of hepatobiliary function.

  Watkins JB 3rd, Sanders RA. Watkins JB 3rd, et al. Pharmacol Rev. 1995 Mar;47(1):1-23. Pharmacol Rev. 1995. PMID: 7784477 Review. No abstract available.